Trusted by:

clients clients clients clients clients clients clients clients clients clients
Released: 19-Sep-2024 3:05 PM EDT
New Combination Treatment Brings Hope to Patients with Advanced Bladder Cancer
University of Chicago Medical Center

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and tolerable in patients with locally advanced or metastatic bladder cancer. The results, which were recently published in JAMA Oncology, show potential to broaden the number of patients with bladder cancer who could benefit from immunotherapy, an approach that harnesses a patient's own immune system to fight cancer.

Newswise: Pushing kidney-stone fragments reduces stones’ recurrence
Release date: 19-Sep-2024 2:05 PM EDT
Pushing kidney-stone fragments reduces stones’ recurrence
University of Washington School of Medicine and UW Medicine

UW Medicine researchers found that patients who underwent the stone-moving ultrasound procedure had a 70% lower risk of such a recurrence. The Journal of Urology published the findings in August.

Newswise: California Streamin’: Jefferson Lab, ESnet Achieve Coast-to-Coast Feed of Real-Time Physics Data
Release date: 19-Sep-2024 1:05 PM EDT
California Streamin’: Jefferson Lab, ESnet Achieve Coast-to-Coast Feed of Real-Time Physics Data
Thomas Jefferson National Accelerator Facility

The test represented the culmination of nearly three years of collaboration between Jefferson Lab and ESnet to develop a novel networking hardware prototype that can connect scientific instruments to computing clusters over a wide-area network such as ESnet’s in real time. The EJFAT device uses traffic-shaping and load-balancing field programmable gate arrays that are designed to allow data from multiple types of scientific instruments to be streamed and processed in real time (or near real time) by multiple high-performance computing facilities.

Newswise: Grants for $3.5M from TARCC fund new Alzheimer’s disease research at UTHealth Houston
Release date: 19-Sep-2024 1:05 PM EDT
Grants for $3.5M from TARCC fund new Alzheimer’s disease research at UTHealth Houston
University of Texas Health Science Center at Houston

Studies by researchers at UTHealth Houston seeking to understand the underlying pathology of Alzheimer’s disease in order to discover new pathways to treatment have earned multiple awards totaling $3.5 million from the Texas Alzheimer’s Research and Care Consortium (TARCC).

Newswise: The Ocean Corporation collaborates with UTHealth Houston on Space Medicine Fellowship program
Release date: 19-Sep-2024 1:05 PM EDT
The Ocean Corporation collaborates with UTHealth Houston on Space Medicine Fellowship program
University of Texas Health Science Center at Houston

UTHealth Houston and The Ocean Corporation are collaborating on UTHealth Houston’s Space Medicine Training Fellowship program, which now includes a two-week intensive training focused on hyperbaric technologies and analog environments akin to those astronauts experience during extravehicular activities (EVAs), or space walks.

Newswise: Poplars' Genetic Adaptation: Unlocking Drought Resistance with miR159a
Released: 19-Sep-2024 12:30 PM EDT
Poplars' Genetic Adaptation: Unlocking Drought Resistance with miR159a
Chinese Academy of Sciences

In a significant advancement for plant biology, researchers have discovered that manipulating miR159a, a key microRNA, enhances drought tolerance in poplar trees. By boosting water-use efficiency and minimizing stomatal opening, this study could revolutionize forestry management in arid regions, offering new strategies for breeding drought-resistant trees to tackle water scarcity challenges.

Newswise: First patient in Texas, Southeast US, enrolled at UTHealth Houston for study of neural cell therapy product to treat epilepsy
Release date: 19-Sep-2024 12:05 PM EDT
First patient in Texas, Southeast US, enrolled at UTHealth Houston for study of neural cell therapy product to treat epilepsy
University of Texas Health Science Center at Houston

UTHealth Houston has enrolled the first patient in the Southeastern United States into a national Phase I/II clinical trial testing whether a neural cell therapy product can help inhibit the abnormal electrical activity that leads to an epileptic seizure.

Newswise: What’s for dinner? Scientists unearth key clues to cuisine of resident killer whales
Release date: 19-Sep-2024 12:05 PM EDT
What’s for dinner? Scientists unearth key clues to cuisine of resident killer whales
University of Washington

Scientists have discovered the cuisine preferences of two resident killer whale populations: the Alaska residents and the endangered southern residents. The two populations show broad preference for salmon, particularly Chinook, chum and coho. But they differ in when they switch to hunting and eating different salmon species, as well as the other fish species they pursue to supplement their diets.

Newswise: New Research Highlights the Unseen Challenges, Adaptations of Adult Daughters During COVID Upheaval for Families
Release date: 19-Sep-2024 12:05 PM EDT
New Research Highlights the Unseen Challenges, Adaptations of Adult Daughters During COVID Upheaval for Families
Baylor University

An innovative Baylor University study has shed light on the often-overlooked experiences of women doing “daughtering” in families, particularly during the COVID-19 pandemic, which created immense challenges in their relationships with parents and other family members.

Released: 19-Sep-2024 12:00 PM EDT
MD Anderson Research Highlights for September 19, 2024
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

   

close
1.95059